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Abstract
Objectives—To examine racial/ethnic-specific survival of children with major birth defects in 
the US.
Study design—We pooled data on live births delivered during 1999-2007 with any of 21 birth 
defects from 12 population-based birth defects surveillance programs. We used the Kaplan-Meier 
method to calculate cumulative survival probabilities and Cox proportional hazards models to 
estimate mortality risk.
Results—For most birth defects, there were small-to-moderate differences in neonatal (<28 
days) survival among racial/ethnic groups. However, compared with children born to non-
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Hispanic white mothers, postneonatal infant (28 days to <1 year) mortality risk was significantly 
greater among children born to non-Hispanic black mothers for 13 of 21 defects (hazard ratios 
[HRs] 1.3-2.8) and among children born to Hispanic mothers for 10 of 21 defects (HRs 1.3-1.7). 
Compared with children born to non-Hispanic white mothers, a significantly increased childhood 
(≤8 years) mortality risk was found among children born to Asian/Pacific Islander mothers for 
encephalocele (HR 2.6), tetralogy of Fallot, and atrioventricular septal defect (HRs 1.6-1.8) and 
among children born to American Indian/Alaska Native mothers for encephalocele (HR 2.8), 
whereas a significantly decreased childhood mortality risk was found among children born to 
Asian/Pacific Islander mothers for cleft lip with or without cleft palate (HR 0.6).
Conclusion—Children with birth defects born to non-Hispanic black and Hispanic mothers 
carry a greater risk of mortality well into childhood, especially children with congenital heart 
defect. Understanding survival differences among racial/ethnic groups provides important 
information for policy development and service planning.
Birth defects are a leading cause of infant death in the US.1 National vital statistics data are 
critical to our understanding of infant mortality2 and child and adult mortality.3,4 However, 
compared with population-based birth defects surveillance systems, birth certificates have 
relatively poor sensitivity and specificity for the reporting of birth defects.5 Linking 
population-based birth defects surveillance data to state death certificates and the National 
Death Index (NDI) can provide high high-quality information on both short- and long-term 
survival of children with birth defects.
There have been several previous studies on survival of infants with birth defects using 
statewide6-14 or regional15-21 population-based birth defects surveillance data. The use of 
pooled data from several surveillance systems in the US, however, has been limited to only a 
few studies of individual defects.22-24 Previous literature suggests that the mortality and 
survival experience of children with birth defects differs by specific birth defect phenotype 
and by demographic factors such as maternal race/ethnicity.12-14,25-28 Racial/ethnic 
disparities in infant and child mortality were found among Florida29 and Texas infants with 
birth defects25,27,28 but not among New York children (up to 25 years) with birth defects.12
To date, no studies using pooled population-based surveillance data have investigated the 
survival of children with a broad range of birth defects. A recent study using pooled data 
from 12 population-based birth defects surveillance programs in the US examined the 
relationship between race/ethnicity and occurrence of selected major birth defects.30 Using 
that study population, in the current study we estimated infant and child survival by birth 
defect subtype and race/ethnicity among live-born individuals with selected birth defects.
Methods
Information on all live births with any of the selected major birth defects was obtained from 
12 participating population-based birth defects surveillance programs: Arizona, Colorado, 
Florida, Georgia (5 counties of metropolitan Atlanta), Illinois, Massachusetts, Michigan, 
Nebraska, New Jersey, New York (excludes New York City), North Carolina, and Texas. 
Surveillance programs matched cases to state birth certificate records to obtain data on 
maternal race/ethnicity, classified as non-Hispanic white (NHW), non-Hispanic black 
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(NHB), Hispanic, Asian/Pacific Islander (A/PI), and American Indian/Alaska Native (AI/
AN). The study protocol was reviewed and approved by the participating states’ institutional 
review boards, as necessary.
The birth defects included in the study were spina bifida without anencephalus; 
encephalocele; common truncus; transposition of great arteries; tetralogy of Fallot; 
atrioventricular septal defect (AVSD) (and a subgroup without co-occurring Down 
syndrome); aortic valve stenosis; hypoplastic left heart syndrome; coarctation of the aorta; 
cleft palate without cleft lip; cleft lip with or without cleft palate; esophageal atresia/s 
tracheoesophageal fistula; pyloric stenosis; rectal, anal, and large intestinal atresia/stenosis; 
upper and lower limb deficiencies; diaphragmatic hernia; gastroschisis; omphalocele; and 
Down syndrome. States selected cases from their surveillance systems for inclusion in this 
analysis based on a list of specified International Classification of Diseases, 9th Revision, 
Clinical Modification or Centers for Disease Control and Prevention/British Pediatric 
Association Classification of Diseases codes that are used for annual reporting by the 
National Birth Defects Prevention Network.31 The birth defects included are not mutually 
exclusive, and infants with multiple defects were included in each relevant birth defect 
category.
Each state surveillance program linked its case information to the state's death certificate 
data files to obtain the vital status information of the study cohort. The follow-up period for 
children in the study ranged from 1 (for those born at the end of 2007 followed through the 
end of 2008) up to 9 years (for those born in the beginning of 1999 followed through the end 
of 2008). Illinois and Nebraska programs only provided vital status information for the first 
year. If a child was deceased, participating programs provided the date of death and duration 
of life in days. Additional data sources used to obtain vital status information included 
hospital discharge files (Arizona, Texas), medical records (Arizona, Texas), and the NDI 
(Georgia, Michigan).
Statistical Analyses
The Kaplan-Meier product limit method was used to calculate survival probabilities (<1 day, 
<7 days, <28 days, <1 year, <2 years, ≤8 years) for specific defects and by maternal race/
ethnicity. Greenwood method was used to calculate 95% CIs. The infant survival analysis 
was conducted using data from all 12 birth defects surveillance programs. For the analyses 
of survival beyond infancy, data for those born during 1999-2005 from 10 programs (note: 
Massachusetts was 2000-2007 and North Carolina was 2003-2007) were analyzed; Illinois 
and Nebraska were excluded from the analyses of survival beyond infancy because they did 
not provide vital status data beyond one year of life. Because the birth cohort for one of the 
participating states (New Jersey) was through 2005 only, 2005 was chosen as the latest birth 
year to be included for all 10 programs in the analysis. Thus, the longest possible period of 
follow-up was just under 9 years (infants born in the beginning of 1999 with follow-up 
though the end of 2008).
Multivariable analyses using Cox proportional hazards models were conducted to estimate 
the mortality risk, the hazard ratio (HR), for each birth defect, with adjustment for the 
following covariates: birth weight and gestational age (<37 weeks and <2500 g, <37 weeks 
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and ≥2500 g, ≥37 weeks and <2500 g, and ≥37 weeks and ≥2500 g),22 maternal age (<35 
and ≥35 years), birth period (1999-2000, 2001-2002, 2003-2005, and 2006-2007), and state 
surveillance program. These variables were selected because bivariate analyses indicated 
these factors were associated with survival (P < .1). Other factors, such as mother's birth 
country, marital status, insurance status, and method of delivery were excluded from the 
multivariable models because they were not available from all participating surveillance 
programs. SAS Version 9.2 (SAS Institute, Cary, North Carolina) was used for all statistical 
analyses.
Results
The study cohort contained 98 833 children born alive in 1999-2007 with at least 1 of the 
selected major birth defects and ascertained from the 12 state surveillance programs (Table 
I; available at www.jpeds.com) among approximately 14 million live births (about 39% of 
all live births in the US during the study period). The study cohort did not include 2007 
births from Colorado, Illinois, Michigan, and Nebraska and 2006-2007 births from New 
Jersey because of unavailability of the vital status data; the earliest available data were 2000 
for Massachusetts and 2003 for North Carolina. A total of 9997 deaths were identified in the 
study cohort, with 8893 (89%) occurring during infancy.
The lowest 1-day and 7-day survival probabilities were found for encephalocele (Table II). 
Children with hypoplastic left heart syndrome had the lowest neonatal (<28 days), infant (<1 
year), and childhood (<2 years and <8 years) survival probability. Of the 21 birth defects 
studied, 6 (spina bifida, cleft palate, cleft lip with or without cleft palate, pyloric stenosis, 
gastroschisis, and Down syndrome) had >90% survival for all ages examined. At every age, 
children with AVSD without co-occurring Down syndrome experienced poorer survival 
than children with AVSD overall.
For most birth defects examined (excluding spina bifida, tetralogy of Fallot, pyloric stenosis, 
and Down syndrome), there were small-to-moderate (≤5%) absolute differences in neonatal 
survival among the 3 major racial/ethnic groups (NHW, NHB, and Hispanic); the 
differences were striking for common truncus, esophageal atresia/tracheoesophageal fistula, 
and diaphragmatic hernia (Table III). Similarly, with the exception of spina bifida, pyloric 
stenosis and Down syndrome, all birth defects exhibited at least a 5% difference in infant 
survival across the 3 major racial/ethnic groups; infants born to NHB and Hispanic mothers 
had consistently lower infant survival than those born to NHW mothers. Neonatal survival 
among infants of A/PI and AI/AN mothers generally was comparable with that of NHW 
mothers with the exceptions of markedly lower survival for encephalocele and hypoplastic 
left heart syndrome, and common truncus (AI/AN only). At least a 5% lower infant survival 
was found among infants of A/PI and AI/AN mothers for several defects: encephalocele, 
common truncus, AVSD, hypoplastic left heart syndrome, coarctation of the aorta, and 
omphalocele.
Similar to infant survival, with the exception of spina bifida, pyloric stenosis, upper limb 
deficiencies, gastroschisis, and Down syndrome, there was 5% or greater variability in early 
childhood survival (<2 years) among the 3 major racial/ethnic groups; the survival 
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probability among children born to NHB mothers was nearly universally lower than that 
among children born to NHW mothers, with the largest difference noted for transposition of 
the great arteries (Table IV). Compared with children of NHW mothers, the survival 
probability among children of A/PI and AI/AN mothers was substantially lower for 
encephalocele, common truncus, AVSD, hypoplastic left heart syndrome, and coarctation of 
the aorta.
Results from multivariable analysis (Table V) showed that, compared with children of NHW 
mothers, the overall childhood (≤8 years) mortality risk was significantly greater among 
children born to NHB mothers for 12 of 21 defects (HR 1.3-2.0), children born to Hispanic 
mothers for 8 defects (HR 1.3-1.6), children born to A/PI mothers for 4 defects (HR 
1.6-2.6), and children born to AI/AN mothers for only 1 defect, encephalocele (HR 2.8). 
However, a significantly decreased overall mortality risk was found among children born to 
A/PI mothers for cleft lip with or without cleft palate (HR 0.6). Among children of A/PI 
mothers, a significantly increased mortality risk was found for hypoplastic left heart 
syndrome (HR 1.6) during the neonatal period and for transposition of great arteries (HR 
3.6) and tetralogy of Fallot (HR 2.4) during early childhood (1-8 years); a significantly 
decreased neonatal mortality risk was found for cleft lip with or without cleft palate (HR 
0.5), compared with children born to NHW mothers.
Discussion
For most of the major birth defects included in this study, we found maternal racial/ethnic 
differences in survival and mortality risk for all survival age groups examined. These 
findings are consistent with previous studies in which the authors used data from a single 
birth defects surveillance program.14,25,27-29 Black-white disparities in mortality risk 
consistently were observed across birth defect types during the postneonatal infancy period 
and continued to widen in childhood for some of the more severe congenital heart defects. 
Racial and ethnic disparities in health often represent potential prevention opportunities, and 
this pattern of changing racial/ethnic disparities across early childhood for these complex 
conditions suggests specific age periods that could be amenable to health services and policy 
interventions that address improved access to and delivery of quality and timely care.
Using the same birth cohort as we did in the current study, others previously have reported 
racial/ethnic disparities in prevalence for several major birth defects.30 Significantly greater 
risks in both overall childhood prevalence as well as increased mortality were found among 
children of NHB mothers for tetralogy of Fallot and AVSD and among children of AI/AN 
mothers for encephalocele, compared with children of NHW mothers.
Our study found that children who had AVSD without co-occurring Down syndrome had 
poorer childhood survival compared with children with both AVSD and Down syndrome 
across all racial/ethnic groups. Previous studies32-34 have shown that children with AVSD 
with a normal chromosome complement had a statistically greater risk of requiring 
reoperation than did children with AVSD and Down syndrome. However, a recent study did 
not find a difference in survival between the 2 groups.20 There is a possibility that a greater 
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proportion of infants with both AVSD and co-occurring Down syndrome are diagnosed 
prenatally compared with infants with AVSD alone.
This study was subject to several limitations. There was a potential for incomplete 
ascertainment of deaths possibly from missed matches of the study cohort to state death 
certificate files or underascertainment of out of state deaths. By potentially missing these 
deaths, we may have overestimated the survival probabilities. However, overall 
ascertainment of deaths for the 2 states that used NDI for vital status determination was not 
appreciably different from that of the other states.
Another limitation was the potential misclassification of birth defect diagnoses for cases 
obtained from the birth defects surveillance programs that rely exclusively on case reporting 
by physicians and hospitals (passive case ascertainment). Seven of the 12 participating 
programs use a passive case-finding methodology, and 4 of these 7 programs validate the 
accuracy of the birth defect case diagnosis through active case follow-up. The 3 programs 
with no case-verification protocol in place would be the most susceptible to 
misclassification. Sensitivity analyses showed that the estimated survival probabilities using 
data from all 12 surveillance programs were 3%-10% greater for 4 of the 21 defects 
compared with the estimated survival probabilities excluding the 3 passive surveillance 
programs (data not shown). The overestimate of survival for the 4 defects could be 
attributable to underascertainment of deaths or misclassification of noncases as cases (more 
likely for congenital heart defects than for encephalocele).
Additional limitations include: (1) wide 95% CIs associated with the estimated survival 
probabilities for several defects among A/PI and AI/AN subgroups attributable to small 
sample sizes; and (2) lack of data on potentially important clinical factors (eg, timing and 
age of the child at initial diagnosis, the severity of the defect, and whether the child had 
isolated or nonisolated defects), demographic factors (eg, socioeconomic status13 and health 
insurance payer29) and hospital factors (eg, nursery care level at the hospital of delivery35) 
that are also likely to play a role. Considering these limitations and the descriptive nature of 
the analysis, the survival estimates presented here should be interpreted cautiously.
Despite these limitations, the survival analyses reported in this study are based on an 
unprecedented dataset. Pooling data from 12 birth defects surveillance programs, all of 
which linked their surveillance data to vital records data enabled the assembly of the largest 
population-based cohort of US infants with birth defects for whom survival up to age eight 
years could be calculated. The defect-specific sample sizes allowed for relatively precise 
survival estimates for most birth defects subtypes. These data also provided an opportunity 
to examine up to 8-year survival among less common racial/ethnic groups (ie, A/PI and 
AI/AN) and for selected defects among NHBs and Hispanics for which no previous survival 
data were available. Future investigations should focus on mortality outcomes associated 
with surgical intervention, co-occurring conditions requiring hospitalization or outpatient 
procedures, and complexity of case presentation for children with specific birth defects.
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Centers that included data for the National Birth Defects Prevention Network include:
Arizona Birth Defects Monitoring Program, Metropolitan Atlanta Congenital Defects 
Program, Colorado Responds to Children with Special Needs, Florida Birth Defects 
Registry, Illinois Adverse Pregnancy Outcomes Reporting System, Massachusetts Birth 
Defects Monitoring Program, Michigan Birth Defects Registry, Nebraska Birth Defects 
Registry, New Jersey Special Child Health Services Registry, New York State Congenital 
Malformations Registry, North Carolina Birth Defects Monitoring Program, and Texas Birth 
Defects Epidemiology, and Surveillance Branch.
Glossary
A/PI Asian/Pacific Islander
AI/AN American Indian/Alaska Native
AVSD Atrioventricular septal defect
HR Hazard ratio
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